TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 2 | 13 | 29 | 158 | 305 | 199 | 118 |
| S | %wins | 50 | 0 | 0 | 0 | 0 | 0 | 8 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/6/05 16:32 | 8/31/05 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sj Strategic Investments LLC | TN | T | S.am | -2,697 | 1.52 | 5 | -1,771 | -31 | 4,002 | D | -78 | -60 | -41 | -9 | 31 | 56 | 43 | -31 | 8 | 15 | 30 | 156 | 306 | 208 | |
9/2/05 18:12 | 8/5/05 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Sj Strategic Investments LLC | TN | T | S.m | -2,697 | 1.52 | 5 | -1,771 | -31 | 4,002 | D | -76 | -58 | -37 | 11 | 42 | 58 | 48 | -36 | -4 | 11 | 28 | 160 | 304 | 190 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |